11/14/2024
3:50 PM | Collegium Pharmaceutical (Issuer)
Karnani Vikram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
4:13 PM | Collegium Pharmaceutical (Subject)
PRINCIPAL GLOBAL INVESTORS (Filed by)
| Form SC 13G | |
11/13/2024
3:30 PM | Collegium Pharmaceutical (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
11/13/2024
1:39 PM | Collegium Pharmaceutical (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
| Form SCHEDULE 13G | |
09/17/2024
3:32 PM | Collegium Pharmaceutical (Issuer)
Smith Thomas B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
9:39 AM | Collegium Pharmaceutical (Subject)
Smith Thomas B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
9:06 AM | Collegium Pharmaceutical (Subject)
Smith Thomas B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
09/06/2024
4:52 PM | Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
10:53 AM | Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
3:47 PM | Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
7:03 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
1:41 PM | Collegium Pharmaceutical (Subject)
McFarlane Neil F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
3:34 PM | Collegium Pharmaceutical (Subject)
McFarlane Neil F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2024
5:02 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
3:50 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2024
3:36 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
4:22 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
12:59 PM | Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
12:11 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
10:19 AM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144/A | |
05/29/2024
9:05 AM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
3:22 PM | Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
11:12 AM | Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
9:05 AM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
3:05 PM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
12:01 PM | Collegium Pharmaceutical (Subject)
Dreyer Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
6:20 PM | BOHLIN GAREN G (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:21 PM | Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:22 PM | Balice-Gordon Rita J. (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:22 PM | Collegium Pharmaceutical (Issuer)
Fallon John A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:22 PM | Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:23 PM | Collegium Pharmaceutical (Issuer)
McFarlane Neil F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:23 PM | Collegium Pharmaceutical (Issuer)
Melincoff Gwen A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:23 PM | Collegium Pharmaceutical (Issuer)
SANTINI GINO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
2:12 PM | BOHLIN GAREN G (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024
7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:02 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:03 AM | Collegium Pharmaceutical (Filer)
| Form DEFA14A | |
05/09/2024
3:07 PM | Collegium Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Strange: Why is Amazon suddenly yielding 39.70%? (Ad) Something big is happening with Amazon stock…
While most investors collect ZERO dividends from Amazon…
A small group just discovered a "backdoor" way to collect yields up to 39.70%! Click here to see this breakthrough before everyone else → |
04/11/2024
7:00 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
3:26 PM | Collegium Pharmaceutical (Issuer)
Smith Thomas B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:24 PM | Collegium Pharmaceutical (Subject)
Smith Thomas B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:14 PM | Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
3:39 PM | Collegium Pharmaceutical (Subject)
Dreyer Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
11:04 AM | Collegium Pharmaceutical (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/12/2024
5:06 AM | Collegium Pharmaceutical (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
01/19/2024
1:40 PM | BlackRock Inc. (Filed by)
Collegium Pharmaceutical (Subject)
| Form SC 13G/A | |
01/18/2024
3:19 PM | Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
7:03 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
3:36 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
4:51 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:28 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
3:32 PM | Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
4:00 PM | Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
